Aarti Pharmalabs has informed that Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held today Monday, May 13, 2024 has approved grant of 40,000 stock options to certain eligible employees of the Company, under the APL Performance Stock Option Plan 2023 (PSOP 2023), subject to the provisions of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, at an exercise price of Rs 5 per option. Each stock option entitles the holder to apply for 1 equity share of the Company of Face Value of Rs 5 each and one-third of the total options granted shall become eligible to vest on each anniversary of grant date for 3 years, subject to continued employment and achievement of performance conditions of Vesting. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 is attached as an 'Annexure A.'
